Yahoo Search Busca da Web

Resultado da Busca

  1. Há 5 dias · The U.S. Southern District of New York has slapped down an effort by Nation of Islam leader Louis Farrakhan against the Simon Wiesenthal Center and the Anti-Defamation League. Judge Denise Cote dismissed on April 5 a $4.8 billion defamation lawsuit brought by Farrakhan and the Nation of Islam against the two Jewish organizations and ...

    • Worldmedianetworks
  2. Há 4 dias · The participants had been vaccinated with 2 doses of BNT162b2, (Pfizer-–BioNTech), ChAdOx1 nCoV-19, (AstraZeneca), or mRNA-1273 (Moderna) vaccine, plus a booster given at least 175 days after a second dose, after September 13, 2021.

  3. Há 2 dias · Although recent vaccine approvals have raised hopes of a turnaround in the pandemic later this year, renewed waves and new variants of the virus pose concerns for the outlook. Amid exceptional uncertainty, the global economy is projected to grow 5.5% in 2021 and 4.2% in 2022.

  4. Há 3 dias · Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers refusals to vaccinate, delaying vaccines, accepting vaccines but remaining uncertain about their use, or using certain vaccines but not others. [1] [2] [3] [4] Although adverse ...

  5. Há 5 dias · He announced a production chain for cholera vaccines to be launched in Africa by the South African biopharmaceutical firm Biovac. Vaccine alliance seeks to raise $9 billion

  6. Há 4 dias · Many of the digital tools PGS turned to had already been piloted pre-COVID. The crisis merely necessitated their rapid uptake. Pfizer and BioNTech’s embrace of novel mRNA science played a pivotal role in achieving a record-breaking COVID-19 vaccine rollout.

  7. Há 16 horas · In early January 2021, the ADL called for the removal of Donald Trump as president in response to the storming of the United States Capitol and described the relationship of the storming of the Capitol to the far-right and antisemitic groups.